Ferroportin Gene Polymorphism, Ferritin, and TIBC Levels Associated with the Severity of COVID-19 among patients: A Sequencing Analysis
Advancements in Life Sciences · 30.12.2025 · 12 (4) · 811
DOI: 10.62940/als.v12i4.2150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advancements in Life Sciences, online erschienen am 30.12.2025. Verfasst von Ban Adnan Hatem und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
SARS-CoV-2 may also be termed a high-load virus due to its rapid spread in the bloodstream. In vitro studies verify that iron chelators can inhibit the virus, indicating iron's key component in viral replication. What's more, increased apoptosis (ferroptosis) due to intracellular accretion of iron has been discovered in biopsy specimens of COVID-19 patients. Unlike harsh pneumonitis, COVID-19 does not demonstrate a hepcidin-initiated accretion of iron at foci of infection, suggesting a different iron metabolism profile.
Methods
This work explored COVID-19 risk and severity according to Ferroportin gene polymorphisms, SNPs rs3811621 and rs10202029. Infected and recovered individuals' samples were utilized for genotypic analysis to observe possible genetic associations.
Result
There were no notable associations of SNP rs3811621 and SNP rs10202029 both with susceptibility to COVID-19, and harshness of the disease. Frequencies of genotype between patient and recovery groups did not differ. Ferritin values, however, were significantly different between mild, severe, and recovery cases. Total iron-binding capacity (TIBC) was significantly lower in recovery subjects than in moderate or severe disease subjects, a predictable and significant finding.
Conclusion
Ferroportin polymorphisms (rs3811621 and rs10202029) do not appear to influence COVID-19 susceptibility and severity. In spite of that, variations in ferritin and TIBC across different patient populations demonstrate their significance as biomarkers in defining iron metabolism during and after infection.Keywords: COVID-19; Ferroportin; ferritin; polymorphism; Sequencing; TIBC
Zitieren
APA
Hatem, B. A., & Jabir, F. A. (2025). Ferroportin Gene Polymorphism, Ferritin, and TIBC Levels Associated with the Severity of COVID-19 among patients: A Sequencing Analysis. Advancements in Life Sciences, 12(4), 811. https://doi.org/10.62940/als.v12i4.2150
Vancouver
Hatem BA, Jabir FA. Ferroportin Gene Polymorphism, Ferritin, and TIBC Levels Associated with the Severity of COVID-19 among patients: A Sequencing Analysis. Advancements in Life Sciences. 2025;12(4):811. doi:10.62940/als.v12i4.2150
BibTeX
@article{Hatem2025,
author = {Hatem, Ban Adnan and Jabir, Ferdous A},
title = {Ferroportin Gene Polymorphism, Ferritin, and TIBC Levels Associated with the Severity of COVID-19 among patients: A Sequencing Analysis},
journal = {Advancements in Life Sciences},
year = {2025},
volume = {12},
number = {4},
pages = {811},
doi = {10.62940/als.v12i4.2150}
}
EUVIMED